CPG-52364

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameCPG-52364
Drug Alias NameCPG-52364
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 7 antagonistsToll like receptor 8 antagonistsToll like receptor 9 antagonists
TargetsToll like receptor 8Toll like receptor 9Toll like receptor 7
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer IncColey Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A